# Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer

> **NCT01648010** · NA · COMPLETED · sponsor: **UroGen Pharma Ltd.** · enrollment: 7 (actual)

## Conditions studied

- Carcinoma of Urinary Bladder, Invasive

## Interventions

- **DEVICE:** TC-3 gel
- **DEVICE:** TC-3 gel mixed with Mitomycin C (MMC)

## Key facts

- **NCT ID:** NCT01648010
- **Lead sponsor:** UroGen Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2013-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648010, "Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01648010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*